Puma Biotechnology, Inc.
NASDAQ:PBYI
2.96 (USD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 235.637 | 228 | 253.2 | 225.1 | 272.3 | 251 | 27.7 | 0 | 0 | 0 | 0 | 0 | -0.281 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 62.682 | 55.1 | 63.7 | 39.4 | 36.8 | 34.6 | 5.6 | 1.149 | 0.776 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 172.955 | 172.9 | 189.5 | 185.7 | 235.5 | 216.4 | 22.1 | -1.149 | -0.776 | 0 | 0 | 0 | -0.281 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.734 | 0.758 | 0.748 | 0.825 | 0.865 | 0.862 | 0.798 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 50.382 | 52.2 | 71.9 | 97.7 | 132.9 | 164.9 | 207.8 | 222.8 | 208.5 | 122.9 | 45.046 | 49.6 | 0.826 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 88.427 | 89.978 | 116.294 | 118.488 | 140.509 | 146.188 | 106.7 | 53.8 | 31.8 | 19.4 | 9.787 | 24.8 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.881 | 0.022 | 0.006 | -0.088 | 1.191 | 0.012 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 89.308 | 90 | 116.3 | 118.4 | 141.7 | 146.2 | 106.7 | 53.8 | 31.8 | 19.4 | 9.787 | 24.8 | 9.32 | 0.016 | 0.017 | 0.014 | 0 |
| Other Expenses
| 0.759 | -0.028 | 0.3 | 0.4 | 0.2 | -9.7 | -0.1 | -0.4 | 0.025 | -0.014 | 0.002 | 0.293 | 0.011 | 0 | 0 | 0 | -15.093 |
| Operating Expenses
| 139.69 | 142.2 | 188.2 | 216.1 | 274.6 | 311.1 | 314.5 | 276.6 | 240.3 | 142.3 | 54.833 | 74.4 | 10.157 | 0.016 | 0.017 | 0.014 | -15.093 |
| Operating Income
| 33.265 | 23.7 | -8.898 | -30.4 | -39.1 | -94.7 | -292.4 | -276.6 | -240.3 | -142.3 | -54.833 | -74.4 | -10.157 | -0.016 | -0.017 | -0.014 | -15.093 |
| Operating Income Ratio
| 0.141 | 0.104 | -0.035 | -0.135 | -0.144 | -0.377 | -10.556 | 0 | 0 | 0 | 0 | 0 | 36.132 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -10.591 | -23.2 | -19.902 | -29.4 | -36.5 | -9.7 | -0.1 | -0.4 | 0.025 | -0.014 | 0.002 | 0.098 | -0.08 | 0 | 0 | 0 | 0 |
| Income Before Tax
| 22.674 | 0.5 | -28.8 | -59.8 | -75.6 | -113.6 | -292 | -276 | -239.3 | -142 | -54.659 | -74.3 | -10.233 | -0.016 | -0.017 | -0.014 | -15.093 |
| Income Before Tax Ratio
| 0.096 | 0.002 | -0.114 | -0.266 | -0.278 | -0.453 | -10.542 | 0 | 0 | 0 | 0 | 0 | 36.403 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.083 | 0.5 | 0.3 | 0.2 | 7.123 | -7.918 | -2.211 | -2.149 | -1.751 | -0.941 | -0.172 | -0.267 | 0.076 | 0 | 0 | 0 | 0 |
| Net Income
| 21.591 | 0.912 | -29.1 | -60 | -82.723 | -113.6 | -292 | -276 | -239.3 | -142 | -54.659 | -74.3 | -10.233 | -0.016 | -0.017 | -0.014 | -15.093 |
| Net Income Ratio
| 0.092 | 0.004 | -0.115 | -0.267 | -0.304 | -0.453 | -10.542 | 0 | 0 | 0 | 0 | 0 | 36.403 | 0 | 0 | 0 | 0 |
| EPS
| 0.46 | 0.02 | -0.72 | -1.52 | -2.13 | -2.99 | -7.86 | -8.29 | -7.45 | -4.73 | -1.9 | -3.42 | -0.51 | -0.002 | -0.006 | -0.005 | -0.38 |
| EPS Diluted
| 0.45 | 0.02 | -0.72 | -1.52 | -2.13 | -2.99 | -7.86 | -8.29 | -7.45 | -4.73 | -1.9 | -3.42 | -0.51 | -0.002 | -0.006 | -0.005 | -0.38 |
| EBITDA
| 44.784 | 31.5 | 1.7 | -29.5 | -36.1 | -102.6 | -291.3 | -276.6 | -240.3 | -142.3 | -54.41 | -74.4 | -10.066 | -0.016 | -0.017 | -0.014 | -15.093 |
| EBITDA Ratio
| 0.19 | 0.138 | 0.007 | -0.131 | -0.133 | -0.409 | -10.516 | 0 | 0 | 0 | 0 | 0 | 35.81 | 0 | 0 | 0 | 0 |